Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study
Brief Communication
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2 February 2018
|
| In: |
Leukemia
Year: 2018, Volume: 32, Issue: 8, Pages: 1799-1803 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/s41375-018-0023-2 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1038/s41375-018-0023-2 Verlag, Volltext: https://www.nature.com/articles/s41375-018-0023-2 
|
| Author Notes: | S. Rule, W. Jurczak, M. Jerkeman, C. Rusconi, M. Trneny, F. Offner, D. Caballero, C. Joao, M. Witzens-Harig, G. Hess, I. Bence-Bruckler, S.-G. Cho, C. Thieblemont, W. Zhou, T. Henninger, J. Goldberg, J. Vermeulen, M. Dreyling |
| Summary: | Brief Communication |
|---|---|
| Item Description: | Gesehen am 30.04.2019 |
| Physical Description: | Online Resource |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/s41375-018-0023-2 |